<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=191312"><dc:title>Synthesis of 3-amino-4-(hydroxymethyl)-β-lactam branch point and its late-stage c4 functionalization with ceftaroline-sidechain monobactams and their biological evaluation</dc:title><dc:creator>Kavaš,	Vid	(Avtor)
	</dc:creator><dc:creator>Golob,	Majda	(Avtor)
	</dc:creator><dc:creator>Meden,	Anže	(Avtor)
	</dc:creator><dc:creator>Hrast Rambaher,	Martina	(Avtor)
	</dc:creator><dc:creator>Gobec,	Stanislav	(Avtor)
	</dc:creator><dc:subject>monobactam</dc:subject><dc:subject>2-azetidinone</dc:subject><dc:subject>late-stage functionalization</dc:subject><dc:subject>penicillin-binding protein</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>click chemistry</dc:subject><dc:subject>antibacterial agents</dc:subject><dc:subject>antimicrobial resistance</dc:subject><dc:description>Monocyclic β-lactams are an underexplored subclass of β-lactam antibiotics active against Gram-negative pathogens, but access to them requires long sequences reported across the patent and primary literature. We compare two alternative routes to 3-amino-4-(hydroxymethyl)-2-azetidinone, a synthon carrying handles at N1, C3 and C4, starting from ethyl glyoxylate and from (R)-glyceraldehyde acetonide. Both are assembled from published transformations; reported here are isolated yields for every step, including the conditions that failed, and execution of the β-lactam-forming sequence on a 50 g scale. Removal of the 2,4-dimethoxybenzyl group was strongly concentration-dependent, giving 94% on the glyoxylate-derived ester against 70% on the acetonide-derived alcohol, whereas the acetonide route replaces a low-yielding NaBH4 ester reduction (43 to 57%) with a near-quantitative oxidative cleavage/reduction sequence. Diverting one late-stage intermediate through copper-catalyzed azide–alkyne cycloaddition or direct thioether alkylation gave three sulfonated monobactams bearing a ceftaroline-derived C4 sidechain, in 0.10 to 0.29% overall yield over 15 steps. None reduced S. pneumoniae PBP1b activity below 50% at 100 μM, against an IC$_{50}$ of 4.93 μM for aztreonam, and none inhibited wild-type E. coli or S. aureus at 128 μg/mL; weak inhibition was seen only in efflux-deficient and outer-membrane-permeabilized E. coli. C4 substitution through either linkage supports activity when the appended group also provides an uptake vector, which the ceftaroline-derived side chain does not, and it conferred no measurable target affinity either</dc:description><dc:date>2026</dc:date><dc:date>2026-11-16 10:12:07</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>191312</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
